Literature DB >> 2171570

Age-related changes in membrane fluidity of erythrocytes in essential hypertension.

K Tsuda1, Y Masuyama.   

Abstract

In the present study, age- and calcium-related changes in the membrane fluidity of erythrocytes were examined in patients with essential hypertension by use of electron spin resonance method (ESR). The erythrocytes were obtained from patients with essential hypertension. We examined the ESR spectra for a fatty acid spin label agent (5-nitroxy stearate) incorporated into the erythrocyte membranes. The values of outer hyperfine splitting and order parameter (S) were significantly higher in subjects with essential hypertension than in the normotensive subjects. This finding indicates that the membrane fluidity of erythrocytes was lower in essential hypertension. Calcium-loading of erythrocytes with the Ca-ionophore A23187 decreased the membrane fluidity (S value was increased) more strongly in essential hypertension than in the normotensive subjects. Furthermore, this Ca-induced change in membrane fluidity was significantly correlated with age in essential hypertension. These results demonstrate that the membrane fluidity of erythrocytes is markedly decreased by calcium, especially in essential hypertension in older patients. This suggests an increased calcium-sensitivity of cell membranes in the aged hypertensive patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171570     DOI: 10.1093/ajh/3.9.714

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  2 in total

1.  Exercise-induced hypoxaemia in master athletes: effects of a polyunsaturated fatty acid diet.

Authors:  B Aguilaniu; P Flore; H Perrault; J E Page; E Payan; J R Lacour
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

2.  Associations between High-Sensitivity C-Reactive Protein and Membrane Fluidity of Red Blood Cells in Hypertensive Elderly Men: An Electron Spin Resonance Study.

Authors:  Kazushi Tsuda
Journal:  Int J Hypertens       Date:  2012-01-31       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.